Linezolid Accord Healthcare Ireland (Linezolid)

Linezolid works by binding to the 23S rRNA of the bacterial 50S ribosomal subunit, which blocks the formation of the initiation complex for protein synthesis. This inhibition prevents the bacteria from producing essential proteins, halting their growth. The effect is bacteriostatic for most Gram‑positive organisms and can become bactericidal at higher drug concentrations.

The exact dose of linezolid is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and other clinical factors. Healthcare professionals follow approved guidelines and adjust therapy as needed; patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for linezolid during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

The primary alternative to linezolid for resistant Gram‑positive infections is vancomycin, a glycopeptide antibiotic. Linezolid offers oral bioavailability, allowing outpatient treatment, whereas vancomycin is administered intravenously. Linezolid also has activity against some strains resistant to vancomycin, but it carries a distinct safety profile, including risks of thrombocytopenia and serotonin syndrome.

Linezolid tablets should be stored at room temperature below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Keep the medication out of reach of children and do not use it after the expiry date printed on the label.

Linezolid is supplied as oral tablets that are swallowed whole with a glass of water. It can be taken with or without food, but consistent administration with respect to meals helps maintain stable blood levels. The prescribed regimen should be followed exactly, and the full course completed even if symptoms improve.

Serious adverse events associated with linezolid include thrombocytopenia, peripheral neuropathy, optic neuropathy, myelosuppression, and serotonin syndrome, especially when combined with serotonergic agents. Patients should report unexplained bruising, vision changes, numbness, or signs of serotonin excess such as agitation or rapid heart rate to their healthcare provider promptly.

Linezolid should be avoided in individuals with known hypersensitivity to linezolid or any component of the formulation. It is also contraindicated in patients currently receiving monoamine oxidase inhibitors (MAOIs) and should be used with caution in those taking serotonergic medications, due to the risk of serotonin syndrome.